Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03869450
Other study ID # 05DF1707
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 9, 2018
Est. completion date August 30, 2019

Study information

Verified date April 2020
Source Galderma R&D
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate the degree of improvement in appearance after treatment with different hyaluronic acid (HA) fillers. Product selection is based on Investigator assessment of participant tissue coverage and main treatment goal (volumizing, lifting or contouring).


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date August 30, 2019
Est. primary completion date August 30, 2019
Accepts healthy volunteers No
Gender All
Age group 25 Years to 55 Years
Eligibility Inclusion Criteria: - Male/Female 25 to 55 years old that needs lifting, contouring or volumization of the midface - Signed and dated informed consent Exclusion Criteria: - Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel and lidocain - Previous use of any permanent or semi-permanent facial tissue augmentation therapy or contouring with, lifting threads, permanent implants, or autologous fat in the treatment area - Previous use of any HA or collagen based facial tissue augmentation therapy in the facial area, any previous use of neurotoxin or any previous facial surgery - Any medical condition that in the opinion of the Investigator would make the participant unsuitable for inclusion

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Restylane Volyme
Hyaluronic based filler
Restylane Defyne
Hyaluronic based filler
Restylane Lyft Lidocaine
Hyaluronic based filler

Locations

Country Name City State
Germany Galderma Research Site Munich
Italy Galderma Research Site Palermo
United Kingdom Galderma Research Site Edinburgh

Sponsors (1)

Lead Sponsor Collaborator
Galderma R&D

Countries where clinical trial is conducted

Germany,  Italy,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants With Aesthetic Improvement of Midface A blinded evaluator assesses the improvement compared to baseline (pre-treatment) using a 5-graded scale; Worse, No change, Improved, Much improved or Very much improved. Aesthetic improvement of midface is defined as those participants assessed as Improved, Much improved or Very much improved. 8 weeks
Secondary Percentage of Participants With Improved Midface Volume A blinded evaluator assessed the fullness of the midface by using a 4-graded scale where 1= fairly full and 4= substantial loss of fullness.
Improved midface volume was defined as at least a 1-grade decrease from baseline.
8 weeks
Secondary Percentage of Participants Assessed as Having Natural Treatment Results Blinded evaluator assessed participants by answering Strongly agree/Agree/Neither agree nor disagree/Disagree/Strongly disagree to the question "Are the subject's treatment results natural looking?". Having natural treatment results is defined as being assessed with answers Strongly agree or Agree. 8 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05963204 - A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen N/A
Completed NCT05622851 - Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers N/A
Recruiting NCT06351358 - Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies N/A
Recruiting NCT05853224 - An Interventional Study to Evaluate the Safety and Performance of Crosslinked Hyaluronic Acid Hydrogel N/A